)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Surgery Partners
Surgery Partners (SGRY) investor relations material
Surgery Partners Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary9 Nov, 2026
Executive summary
Q3 revenue fell 0.8% YoY to $815.3M, reflecting the Idaho divestiture, partly offset by 6.0% days-adjusted same-facility revenue growth.
Adjusted EBITDA was $132.7M, down 2.7% YoY; net loss attributable to common stockholders narrowed to $21.1M from $22.7M.
The amended merger agreement provides $25.00 cash per eligible share, with closing expected in Q1 2027 subject to approvals and other conditions.
Financial highlights
Q3 revenue was $815.3M vs. $821.5M; operating income was $85.6M vs. $105.7M, and consolidated net income was $14.1M vs. $25.3M.
Q3 diluted loss per share was $0.16 vs. $0.18; 9M loss per share was $0.56 vs. $0.50.
9M revenue was $2,475.1M vs. $2,423.7M; net loss attributable to common stockholders was $72.0M vs. $62.9M.
9M operating income was $253.5M vs. $279.3M; Adjusted EBITDA was $360.2M vs. $369.3M.
Outlook and guidance
Forward-looking guidance was discontinued during the pending transaction, and no earnings conference call will be held.
Operating cash flow, cash on hand, Revolver capacity and anticipated capital-market access are expected to meet liquidity needs at current operating levels.
Priorities remain same-facility performance, selective acquisitions of established facilities, new-facility development and portfolio management initiatives.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Surgery Partners
- Amended HealthSpan deal raises value to up to ~$6.0B with capped per-share delay payments.SGRY
Proxy filing - Board backs HealthSpan’s amended ~$6.0B all-cash deal, targeting a Q1 2027 close.SGRYProxy filing
- Revised merger offers $25 per share plus up to $1.61 in delay payments.SGRYProxy filing
- Proposed $5.7B all-cash sale targets Q1 2027 close, pending approvals.SGRYProxy filing
- HealthSpan Partners deal targets a Q1 2027 close, pending approvals and a shareholder vote.SGRYProxy filing
- HealthSpan Partners’ ~$5.7B cash acquisition awaits shareholder and regulatory approval.SGRYProxy filing
- A $23.50-per-share acquisition combines cash consideration with Bain Capital’s equity rollover.SGRYProxy filing
- Q2 2026 revenue rose 2.7%, guidance reaffirmed, and Idaho Falls divestiture to generate $795M.SGRYQ2 2026
- Q3 revenue rose 14.3% and Adjusted EBITDA 21.9%, led by high acuity cases and acquisitions.SGRYQ3 2024
Next Surgery Partners earnings date
Q4 20262 Mar, 2027
Surgery Partners
Next Surgery Partners earnings date
Q4 20262 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Surgery Partners Inc. is a healthcare services company specializing in the operation of surgical facilities and ancillary services. The company manages a network of ambulatory surgery centers and surgical hospitals, offering procedures across specialties such as orthopedics, gastroenterology, and ophthalmology. Surgery Partners serves patients, physicians, and healthcare providers with a focus on high-quality, cost-effective care. The company is headquartered in Brentwood, Tennessee, and its shares are listed on the NASDAQ.